NAP1L5 and acute myeloid leukemia: GSEA revealed that NAP1L5 expression predominantly impacts olfactory signal transduction, neural signal transduction, programmed cell death, and DNA replication pathways in AML, suggesting its involvement in multiple signaling pathways that regulate disease onset and progression.